Open original FDA record ↗Recall record
- FDA identifier
- Z-1099-2021
- Company in FDA record
- Cytocell Ltd.
- FDA record creation date
- Feb 8, 2021
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Users may observe very faint additional locus specific signals at 11q13. There is a low risk of a normal sample being reported as not normal in a resulting laboratory developed test (LDT) that utilizes the LPH511-A CRLF2 Distal Probe Green.
Source facts
- Action
- The firm began distributing recall notifications to customers on December 22, 2020. Customers were informed of the product issue. Customers were instructed to do the following: Immediately examine your inventory and quarantine all product subject to recall. The firm requests that you destroy the remaining inventory. The firm also suggests that laboratories review any results obtained with the affected devices and check that signal patterns were not misinterpreted as a result of any additional locus specific signal at 11q13. If you have any questions, contact Cytocell on Tel: +44 (0)1223 294048, Fax +44(0)1223 294986 or vigilance@ogt.com.
- Initiated
- 2020-12-22
- Root cause
- Under Investigation by firm
- Terminated
- 2022-06-07
- Distribution
- Domestic distribution to California, Illinois, Michigan, Minnesota, New Jersey, Texas, and Washington. Foreign distribution to Canada.
- Recall number
- Z-1099-2021
- Recall status
- Terminated
- CDRH record ID
- 185313
- FDA record created
- 2021-02-08
- Recall event number
- 87090